Evaluation of damage in giant cell arteritis.

about

Evaluation of damage in giant cell arteritis.

Item

http://www.wikidata.org/entity/Q46097662

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Evaluation of damage in giant cell arteritis.

@en

Evaluation of damage in giant cell arteritis.

@nl

type

Item

label

Evaluation of damage in giant cell arteritis.

@en

Evaluation of damage in giant cell arteritis.

@nl

prefLabel

Evaluation of damage in giant cell arteritis.

@en

Evaluation of damage in giant cell arteritis.

@nl

P1476

Evaluation of damage in giant cell arteritis.

@en

P2093

Antoine G Sreih

http://www.w3.org/2001/XMLSchema#string

Carol A Langford

http://www.w3.org/2001/XMLSchema#string

Carol A McAlear

http://www.w3.org/2001/XMLSchema#string

Christian Pagnoux

http://www.w3.org/2001/XMLSchema#string

Curry L Koening

http://www.w3.org/2001/XMLSchema#string

David Cuthbertson

http://www.w3.org/2001/XMLSchema#string

Gary S Hoffman

http://www.w3.org/2001/XMLSchema#string

Kenneth J Warrington

http://www.w3.org/2001/XMLSchema#string

Larry Moreland

http://www.w3.org/2001/XMLSchema#string

Nader A Khalidi

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical practice. Giant-cell arteritis and polymyalgia rheumatica

Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials.

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials.

Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).

Disease pattern in cranial and large-vessel giant cell arteritis.

Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis

Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.

The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/KEX397

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29112740

http://www.w3.org/2001/XMLSchema#string

P932

5850105

http://www.w3.org/2001/XMLSchema#string